FDA advisory committee does not favor approval of temozolomide for melanoma indication April 29, 1999
Licensing opportunity from NIH: lavendustin A analogues with antiproliferative activity April 29, 1999
Synthetic antitumor agent derived from Et 743 shows promise following preliminary testing April 27, 1999
RSS